These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26596421)

  • 21. Determining VA physician requirements through empirically based models.
    Lipscomb J; Kilpatrick KE; Lee KL; Pieper KS
    Health Serv Res; 1995 Feb; 29(6):697-717. PubMed ID: 7860320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the cost distribution report in estimating private sector payments: what adjustments should researchers make?
    Nugent G; Grippen G; Parris YC; Mitchell M
    Med Care; 2003 Jun; 41(6 Suppl):II80-90. PubMed ID: 12773830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of VA-sponsored research.
    Barnett PG; Garber AM
    Acad Med; 1996 Oct; 71(10):1074-8. PubMed ID: 9177641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Federal and nationwide intensive care units and healthcare costs: 1986-1992.
    Halpern NA; Bettes L; Greenstein R
    Crit Care Med; 1994 Dec; 22(12):2001-7. PubMed ID: 7988140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and cost of the inpatient treatment of posttraumatic stress disorder: comparison of three models of treatment.
    Fontana A; Rosenheck R
    Am J Psychiatry; 1997 Jun; 154(6):758-65. PubMed ID: 9167502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving cost-effectiveness in a substance abuse treatment program.
    Francis E; Hughes P; Schinka J
    Psychiatr Serv; 1999 May; 50(5):633-5. PubMed ID: 10332897
    [No Abstract]   [Full Text] [Related]  

  • 29. Estimating lost revenue from a free-care mandate in the U.S. Department of Veterans Affairs.
    Smith MW; Chow A; Kimerling R
    Psychiatr Serv; 2010 Nov; 61(11):1150-2. PubMed ID: 21041357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What would VA nursing home care cost? Methods for estimating private sector payments.
    Hendricks A; Whitford J; Nugent G
    Med Care; 2003 Jun; 41(6 Suppl):II52-60. PubMed ID: 12773827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems due to medication costs among VA and non-VA patients with chronic illnesses.
    Piette JD; Heisler M
    Am J Manag Care; 2004 Nov; 10(11 Pt 2):861-8. PubMed ID: 15609740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of access as demand for substance use disorder treatment grows.
    Frakt AB; Trafton J; Pizer SD
    J Subst Abuse Treat; 2015 Aug; 55():58-63. PubMed ID: 25795602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-year risk-adjusted mortality and costs of percutaneous coronary intervention in the Veterans Health Administration: insights from the VA CART Program.
    Ho PM; O'Donnell CI; Bradley SM; Grunwald GK; Helfrich C; Chapko M; Liu CF; Maddox TM; Tsai TT; Jesse RL; Fihn SD; Rumsfeld JS
    J Am Coll Cardiol; 2015 Jan; 65(3):236-42. PubMed ID: 25614420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the Decision Support System for VA cost-effectiveness research.
    Barnett PG; Rodgers JH
    Med Care; 1999 Apr; 37(4 Suppl Va):AS63-70. PubMed ID: 10217386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of VA adult day health care programs and their effect on utilization and cost of care.
    Ehreth J; Chapko M; Hedrick SC; Savarino JE
    Med Care; 1993 Sep; 31(9 Suppl):SS50-61. PubMed ID: 8361248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and Productivity Benefits of the Department of Veterans Affairs Maintaining Internal Systems and Strengthening Integrated Outside Networks Act Scribes Trial.
    Shafer PR; Palani S; Saeed I; Legler A; Barr K; Carvalho K; Pizer SD
    Value Health; 2024 Jun; 27(6):713-720. PubMed ID: 38462222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental disorders and quality of diabetes care in the veterans health administration.
    Desai MM; Rosenheck RA; Druss BG; Perlin JB
    Am J Psychiatry; 2002 Sep; 159(9):1584-90. PubMed ID: 12202281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
    Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
    Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system.
    Onukwugha E; Mullins CD; DeLisle S
    Value Health; 2008; 11(5):980-8. PubMed ID: 18194405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of mental health services by women in a male-dominated environment: the VA experience.
    Hoff RA; Rosenheck RA
    Psychiatr Serv; 1997 Nov; 48(11):1408-14. PubMed ID: 9355167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.